Arrowstreet Capital’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-57,964
Closed -$592K 1917
2025
Q2
$592K Buy
57,964
+20,781
+56% +$183K ﹤0.01% 1716
2025
Q1
$294K Buy
+37,183
New +$458K ﹤0.01% 1694
2021
Q3
Sell
-7,400
Closed -$790K 1629
2021
Q2
$790K Buy
+7,400
New +$728K ﹤0.01% 1596
2020
Q3
Sell
-170,391
Closed -$6.96M 2358
2020
Q2
$6.96M Buy
170,391
+11,271
+7% +$324K 0.01% 925
2020
Q1
$2.45M Buy
159,120
+51,079
+47% +$1.07M 0.01% 986
2019
Q4
$2.44M Buy
+108,041
New +$1.77M 0.01% 1075

Other funds holding CRNC

Arrowstreet Capital's CRNC Position: Q3 2025 in Review

Arrowstreet Capital sold out of Cerence (CRNC) in Q3 2025, closing a stake of 57,964 shares — an estimated $592K sold.

Arrowstreet Capital first reported a position in CRNC in Q4 2019 and held it in 6 quarters. The position peaked at $6.96M in Q2 2020. 189 funds tracked by Wall St. Rank hold CRNC as of Q3 2025.

  • Arrowstreet Capital reported no remaining Cerence position as of Q3 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 57,964 Cerence shares in Q3 2025, an estimated $592K.
  • Arrowstreet Capital first reported a position in Cerence in Q4 2019 and held it in 6 quarters.
  • Arrowstreet Capital's Cerence position peaked at $6.96M in Q2 2020.
  • 189 funds tracked by Wall St. Rank held Cerence as of Q3 2025.

Based on Arrowstreet Capital's 13F filing for Q3 2025, filed 13 Nov 2025.